WOLVERINE TRADING, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 74 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
WOLVERINE TRADING, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$13
-100.0%
23,700
-35.2%
0.00%
Q3 2022$43,000
+95.5%
36,595
+91.6%
0.00%
Q1 2022$22,000
-85.7%
19,100
-71.0%
0.00%
Q4 2021$154,000
-54.2%
65,800
-39.0%
0.00%
Q2 2021$336,000
-11.1%
107,942
-13.7%
0.00%
Q1 2021$378,000
+822.0%
125,147
+572.8%
0.00%
Q4 2020$41,000
-32.8%
18,600
-63.6%
0.00%
Q4 2018$61,000
+3.4%
51,029
+136.2%
0.00%
Q3 2018$59,000
-28.0%
21,600
-44.9%
0.00%
Q2 2018$82,0000.0%39,2100.0%0.00%
Q1 2018$82,000
+26.2%
39,210
+22.9%
0.00%
Q4 2017$65,000
+62.5%
31,900
+30.2%
0.00%
Q2 2017$40,000
-71.4%
24,500
-41.7%
0.00%
Q1 2017$140,000
+211.1%
42,039
+26.7%
0.00%
Q4 2016$45,000
+9.8%
33,184
+23.3%
0.00%
Q3 2016$41,000
+95.2%
26,903
+76.3%
0.00%
Q2 2016$21,00015,2570.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,100,000$14,762,0006.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,882,805$52,107,0001.90%
Cheyne Capital Management (UK) LLP 326,821$4,388,0001.56%
BB BIOTECH AG 2,320,737$31,144,0001.27%
Broadfin Capital, LLC 854,384$11,466,0001.20%
HealthCor Management, L.P. 1,162,200$15,597,0000.80%
Orbimed Advisors 4,736,900$63,569,0000.66%
Rhenman & Partners Asset Management AB 148,000$1,986,0000.58%
SOUND ENERGY PARTNERS, INC. 51,000$684,0000.53%
Rock Springs Capital Management LP 210,000$2,818,0000.44%
View complete list of INFINITY PHARMACEUTICALS INC shareholders